D METZ1, NHOLFORD2, J KAUSMAN1, N CRANSWICK1, A WALKER1, F IERINO3 1Royal Children’s Hospital, Parkville, Australia, 2University of Auckland, Auckland, New Zealand, 3St Vincent’s Hospital Melbourne, Fitzroy, Australia Mycophenolic acid (MPA) underexposure in the immediate post-transplant period occurs in ~25%...
- 8 June 2018
D METZ1, N HOLFORD2, JKAUSMAN1, N CRANSWICK1, AWALKER1, F IERINO3 1Royal Children’s Hospital, Elsternwick, Australia, 2University of Auckland, Auckland, New Zealand, 3St Vincent’s Hospital Melbourne, Fitzroy, Australia Aims: To define key immunosuppressant eras as reflected in the ANZDATA transplant registry...
- 8 June 2018
J LING1, T COUGHLAN1, K POLKINGHORNE1, J KANELLIS1 1Monash Medical Centre, Clayton, Australia Aim: To critically appraise the ability of risk indices (RI) to predict pancreas transplantation (PTx) outcomes. Background: RI using donor/recipient characteristics assist in organ allocation and acceptance...
- 8 June 2018
E CASH1, G BRAILSFORD1, N WATSON2, G KIRKLAND2, M JOSE1,2,3 1School of Medicine, University Of Tasmania, Hobart, Australia, 2Renal Unit, Royal Hobart Hospital, Hobart, Australia, 3Australia and New Zealand Dialysis and Transplant Registry (ANZDATA), , Australia Aim: To audit the...
- 8 June 2018
P KOTAGIRI1, R MASTERSON1, P HUGHES1, K BARRACLOUGH1 1Royal Melbourne Hospital, Parkville, Australia Aim: To examine for associations between mycophenolic acid (MPA) exposure at week 5 (w5) and month 3 (m3) post-kidney transplant and clinical outcomes in recipients treated with...
- 8 June 2018
MP PRAKASH1,4, TZHUO1, J HEDLEY2, A WEBSTER1,3, L KAIRAITIS4, N ROGERS1,3 1The Westmead Institue For Medical Research, Westmead Hospital, Westmead, Australia, 2Sydney School of Public Health, Sydney, Australia, 3Centre for Transplant and Renal Research, Westmead Millennium Institute, Westmead, Australia, 4Western...
- 8 June 2018
J HA1,2, A HOFFMAN1, MA BROWN1,2 1Department of Renal Medicine, St George Hospital, Sydney, Australia, 2St George Clinical School, UNSW Medicine, Sydney, Australia Aim/Background: The symptom burden in end-stage renal disease has been well documented but little is known about...
- 8 June 2018
H LIEW1,2, M ROBERTS1,2, L MCMAHON1,2 1Department of Renal Medicine, Box Hill, Australia, 2Monash University, Melbourne, Australia Background: The endothelial glycocalyx (EG) on the vascular luminal surface contributes to endothelial health and function. Damage to this layer is indicative of...
- 8 June 2018
N DE LA MATA1, P CLAYTON2,3, S MCDONALD2,3,4, S CHADBAN2,5,6, K POLKINGHORN7,8, AC WEBSTER1,9 1Sydney School Of Public Health, The University Of Syd, Camperdown, Australia, 2Australian and New Zealand Dialysis and Transplant (ANZDATA) Registry, Adelaide, Australia, 3Central Northern Adelaide Renal and...
- 8 June 2018
E AU1,2,3, J CHAPMAN2, A TEIXEIRA-PINTO1,3, J CRAIG1,3, G WONG1,2,3 1Centre for Kidney Research, The Children’s Hospital at Westmead, , Sydney, Australia, 2Centre for Transplant and Renal Research, Westmead Hospital, Sydney, Australia, 3School of Public Health, Faculty of Medicine, University...
- 8 June 2018